mannosebind
lectin
mbl
play
major
role
immun
respons
solubl
patternrecognit
receptor
mbl
defici
suscept
differ
type
infect
subject
extens
studi
last
decad
human
chicken
sever
studi
shown
mbl
particip
protect
host
viru
infect
infecti
bronchiti
ib
highli
contagi
diseas
econom
import
poultri
industri
caus
coronaviru
infecti
bronchiti
viru
ibv
mbl
earlier
describ
play
potenti
role
pathogenesi
ibv
infect
product
ibvspecif
antibodi
may
exploit
optimis
ibv
vaccin
strategi
present
studi
show
mbl
capabl
bind
ibv
vitro
chicken
two
inbr
line
select
high
low
mbl
serum
concentr
respect
vaccin
ibv
without
addit
mbl
ligand
mannan
chitosan
fructooligosaccharid
fo
addit
mbl
ligand
ibv
vaccin
especi
fo
enhanc
product
ibvspecif
igg
antibodi
product
chicken
chicken
second
vaccin
addit
fo
vaccin
also
increas
number
circul
cell
chicken
compar
chicken
chicken
well
chicken
also
show
increas
number
tcell
mbl
ligand
ad
vaccin
pronouncedli
first
vaccin
mbl
ligand
coadminist
ibv
vaccin
induc
differ
two
chicken
line
result
indirectli
suggest
mbl
involv
immun
respons
ibv
vaccin
furthermor
higher
antibodi
respons
chicken
receiv
vaccin
fo
make
fo
potenti
adjuv
candid
ibv
vaccin
first
line
host
defenc
pathogen
involv
innat
immun
system
pathogen
specif
microorganismassoci
molecular
pattern
mamp
recognis
patternrecognit
receptor
prr
two
kind
prr
exist
surfac
prr
solubl
prr
prr
trigger
intracellular
signal
cascad
upon
mamp
recognit
culmin
activ
antigen
present
cell
product
costimulatori
molecul
well
proinflammatori
cytokin
product
costimulatori
molecul
proinflammatori
cytokin
initi
earli
host
respons
infect
also
partak
activ
shape
adapt
immun
respons
crozat
et
al
de
visser
coussen
hoffmann
et
al
sever
solubl
prr
describ
exampl
mannosebind
lectin
mbl
mbl
variou
function
exampl
complement
activ
promot
complementindepend
opsonophagocytosi
modul
inflamm
recognit
alter
selfstructur
apoptot
cell
clearanc
dommett
et
al
mbl
collectin
consist
multipl
ident
polypeptid
chain
oligomeris
differ
size
chain
made
four
distinct
domain
cysteinerich
ntermin
domain
collagen
domain
neck
domain
calciumdepend
carbohydraterecognit
domain
crd
ctermin
takahashi
crd
permit
mbl
bind
ca
depend
manner
mamp
polysaccharid
fact
termin
sugar
dmannos
lfucos
nacetyldglucosamin
found
surfac
mani
microorgan
contain
equatori
group
mbl
bind
mbl
bind
dgalactos
sialic
acid
found
surfac
mani
anim
cell
besid
sugar
mbl
also
found
bind
phospholipid
nucleic
acid
nonglycosyl
protein
ip
et
al
mbl
gene
human
madsen
et
al
madsen
et
al
steffensen
et
al
sumiya
et
al
porcin
juulmadsen
et
al
lilli
et
al
bovin
liu
et
al
chicken
kjaerup
et
al
found
polymorph
result
wide
variat
mbl
serum
level
organ
last
decad
mbl
defici
influenc
suscept
differ
type
infect
subject
extens
studi
review
heitzened
et
al
mayilyan
takahashi
result
indic
mbl
defici
may
actual
benefici
regard
diseas
exampl
viscer
leishmaniasi
santo
et
al
howev
result
suggest
mbl
defici
lead
weaker
immun
respons
human
sever
studi
shown
mbl
particip
protect
host
viru
infect
infect
influenza
viru
chang
et
al
hepat
c
viru
brown
et
al
ebola
viru
michelow
et
al
sever
acut
respiratori
syndrom
sar
coronaviru
ip
et
al
zhou
et
al
thu
mbl
chicken
may
also
play
role
pathogenesi
chicken
viru
infect
product
antibodi
suggest
juul
madsen
et
al
select
breed
chicken
low
high
serum
mbl
concentr
perform
sever
gener
depart
publish
juul
madsen
et
al
result
two
distinct
chicken
line
design
high
low
mean
serum
mbl
concentr
gml
serum
gml
serum
gener
unpublish
studi
use
chicken
sublin
well
outbr
chicken
shown
invers
relationship
mbl
concentr
pathogenspecif
antibodi
respons
juulmadsen
et
al
schou
et
al
studi
mice
shown
mbl
defici
may
result
higher
igg
antibodi
respons
infect
carter
et
al
vaccin
guttormsen
et
al
result
hypothesis
basal
mbl
plasma
level
may
influenc
specif
humor
immun
respons
explan
may
either
mbl
push
immun
respons
cellular
respons
vs
mbl
effici
neutralis
pathogen
via
complement
membraneattack
complex
adapt
immun
respons
need
mbl
influenc
proinflammatori
cytokin
product
via
interact
surfac
receptor
tolllik
receptor
ip
et
al
infecti
bronchiti
ib
highli
contagi
diseas
econom
import
poultri
industri
symptom
sneez
tracheal
rale
cough
furthermor
ib
may
caus
declin
egg
qualiti
product
layer
raj
jone
ib
caus
coronaviru
infecti
bronchiti
viru
ibv
highli
abl
genet
mutat
recombin
result
continu
develop
new
strain
throughout
world
differ
strain
cocircul
within
region
sever
diseas
vari
strain
strain
flock
flock
capua
et
al
cavanagh
cook
et
al
consequ
appli
vaccin
sometim
provid
insuffici
protect
vaccin
one
strain
ibv
may
protect
strain
vaccin
efficaci
may
improv
use
adjuv
good
candid
vaccin
adjuv
carbohydr
sinc
mostli
low
toxic
high
biocompat
furthermor
play
major
role
within
immun
system
petrovski
cooper
carbohydr
mannan
liu
et
al
chitosan
rauw
et
al
fructooligosaccharid
fo
benyacoub
et
al
previous
use
vaccin
diet
modul
immun
respons
three
carbohydr
potenti
mbl
ligand
owe
content
sugar
unit
hypothesi
studi
immun
ibv
vaccin
may
improv
temporarili
inhibit
mbl
function
achiev
ad
mbl
ligand
mannan
chitosan
fo
vaccin
given
chicken
therebi
creat
artifici
mbl
defici
vaccin
innat
well
adapt
immunolog
paramet
measur
throughout
experiment
period
chemic
obtain
sigmaaldrich
ballerup
denmark
except
note
dreamtaq
tm
master
mix
obtain
qiagen
oligonucleotid
primer
probe
obtain
eurofin
mwg
operon
ebersberg
germani
purifi
chicken
mbl
bought
depart
cancer
inflamm
research
univers
southern
denmark
purifi
chicken
serum
previous
describ
laursen
et
al
bind
capac
mbl
ibv
measur
use
elisa
dilut
purifi
mbl
serum
sampl
chicken
made
without
addit
saccharid
biowhittak
veron
buffer
lonza
walkersil
md
usa
cat
adjust
final
concentr
mm
mgcl
mm
cacl
use
dilut
sampl
titrat
mbl
bind
concentr
gml
purifi
mbl
use
l
serum
sampl
dilut
concentr
saccharid
ad
follow
mannan
mgml
fo
mgml
chitosan
mgml
galactos
mgml
edta
mm
onehundr
microlitr
dilut
saccharid
mix
nunc
polypropylen
microwel
plate
thermo
fisher
scientif
slangerup
denmark
cat
incub
min
sampl
transfer
microtitr
plate
coat
ibv
antigen
proflok
ibv
antibodi
test
kit
synbiot
corpor
san
diego
ca
usa
cat
well
receiv
buffer
use
neg
control
dilut
ad
triplic
plate
incub
room
temperatur
h
wash
step
gibco
dpb
supplement
calcium
magnesium
life
technolog
europ
bv
naerum
denmark
cat
ph
adjust
follow
supplement
bsa
hereaft
call
pb
well
incub
min
room
temperatur
gml
biotinyl
monoclon
mous
anticmbl
bioporto
diagnost
gentoft
denmark
cat
hyb
pb
anoth
wash
step
streptavidin
horseradish
peroxidas
savhrp
bd
biosciens
albertslund
denmark
cat
dilut
pb
ad
min
incub
wash
pb
presenc
savhrp
detect
ad
ml
substrat
solut
wtwt
tetramethylbenzidin
colour
develop
stop
h
solut
colour
develop
determin
read
absorb
nm
absorb
nm
refer
gener
two
au
inbr
sublin
juul
madsen
et
al
use
studi
n
chicken
consist
white
cornish
laursen
et
al
offspr
rear
togeth
biosecur
ibvfre
environ
week
age
alloc
differ
treatment
group
bird
sublin
group
first
treatment
group
treat
l
deioniz
water
contain
one
dose
live
attenu
nobili
ib
msd
anim
health
ballerup
denmark
danish
product
licens
per
anim
second
treatment
group
treat
l
deioniz
water
contain
one
dose
live
attenu
nobili
ib
vet
mgml
purifi
mannan
saccharomys
cerevisia
per
anim
aim
g
mannan
per
gram
bodi
weight
juul
madsen
et
al
third
treatment
group
treat
l
deioniz
water
contain
one
dose
live
attenu
nobili
ib
vet
mgml
deactyl
chitosan
shrimp
shell
per
anim
fourth
treatment
group
treat
l
deioniz
water
contain
one
dose
live
attenu
nobili
ib
vet
mgml
fo
orafti
alsiano
denmark
per
anim
aim
g
fo
per
gram
bodi
weight
solut
shaken
nasal
appli
chicken
three
week
four
treatment
group
vaccin
amount
vaccin
saccharid
first
vaccin
chicken
fed
diet
met
exceed
nrc
requir
food
water
provid
ad
libitum
experiment
procedur
conduct
protocol
approv
danish
anim
experi
inspector
compli
danish
ministri
justic
law
june
act
decemb
may
concern
anim
experiment
care
experiment
anim
serum
collect
blood
sampl
ml
taken
jugular
vein
wing
vein
experiment
chicken
day
post
vaccin
heparinstabilis
blood
immunophenotyp
collect
week
day
collect
blood
ml
divid
one
serum
tube
one
heparin
tube
oropharyng
airway
opa
swab
sampl
collect
day
swab
sampl
kept
ml
viru
media
gibco
penicillinstreptomycin
life
technolog
europ
bv
naerum
denmark
cat
biowhittak
pb
lonza
vervier
belgium
cat
biowittak
foetal
bovin
serum
lonza
vervier
belgium
cat
phenol
red
merck
darmstadt
germani
cat
c
test
realtim
quantit
revers
transcript
pcr
qrtpcr
termin
experi
mbl
haplotyp
determin
mean
taqman
snp
genotyp
techniqu
appli
biosystem
foster
citi
ca
usa
two
assay
design
use
custom
taqman
assay
design
tool
accord
instruct
websit
http
genotyp
assay
distinguish
cg
ta
allel
gggg
agga
allel
kjaerup
et
al
assay
valid
run
microtitr
plate
abi
prism
sequenc
detect
system
instrument
use
version
sd
softwar
total
reaction
volum
l
appli
sampl
contain
l
taqman
univers
pcr
mastermix
appli
biosystem
life
technolog
europ
bv
naerum
denmark
cat
l
assay
mix
l
h
l
dna
concentr
ngl
ensur
optim
cluster
posit
control
repres
anim
known
genotyp
includ
run
togeth
four
nontempl
neg
control
amplif
obtain
initi
incub
period
min
c
follow
cycl
denatur
c
annealingextens
min
c
amplif
endpoint
read
carri
analysi
perform
call
enabl
sd
softwar
version
fortyseven
microlitr
three
swab
sampl
sublin
treatment
group
day
pool
thu
pool
per
sublin
analys
time
point
rna
purif
done
use
qiaamp
viral
rna
mini
kit
qiagen
copenhagen
denmark
cat
accord
manufactur
instruct
revers
transcript
pcr
carri
use
highcapac
cdna
archiv
kit
appli
biosystem
life
technolog
europ
bv
naerum
denmark
cat
accord
manufactur
instruct
l
rna
real
time
quantit
revers
transcript
pcr
qrtpcr
reaction
perform
forward
primer
revers
primer
duallabel
probe
g
probe
previous
describ
amplifi
least
differ
strain
ibv
callison
et
al
total
reaction
volum
l
contain
l
taqman
univers
pcr
master
mix
appli
biosystem
life
technolog
europ
bv
naerum
denmark
cat
primer
probe
l
cdna
templat
reaction
perform
abi
prism
sequenc
detect
system
c
min
c
min
optic
cycl
c
follow
c
min
optic
standard
curv
includ
qrtpcr
run
gener
dilut
cdna
origin
purifi
rna
live
attenu
nobili
ib
vet
standard
curv
made
dilut
start
one
dose
correspond
minimum
eid
accord
manufactur
instruct
result
express
viral
load
accord
standard
curv
howev
viral
load
measur
viral
rna
true
viral
replic
qrtpcr
experi
contain
triplic
notempl
control
test
sampl
dilut
seri
nobili
ib
vet
cdna
iggspecif
antibodi
titr
ibv
serum
measur
previous
describ
juulmadsen
et
al
use
proflok
ibv
antibodi
test
kit
synbiot
corpor
san
diego
ca
usa
cat
accord
manufactur
instruct
absolut
number
differ
tcell
subset
peripher
blood
measur
week
use
nolys
nowash
flow
cytometr
method
fifti
microlitr
time
dilut
heparinstabilis
blood
mix
l
antibodi
solut
contain
l
clone
fac
buffer
bsa
sodium
azid
normal
hors
serum
pb
monoclon
antibodi
obtain
southern
biotech
birmingham
al
usa
sampl
incub
room
temperatur
min
ml
tube
dark
immedi
acquisit
l
facsbuff
l
flowcount
tm
fluorospher
beckman
coulter
ireland
mervu
galway
ireland
cat
ad
bcell
number
measur
week
protocol
describ
use
l
clone
fac
buffer
posit
macrophag
monocyt
subset
avoid
fscssc
gate
small
lymphocyt
flow
cytometr
analys
perform
bd
facscanto
tm
bd
bioscienc
san
jose
ca
usa
equip
nm
blue
laser
nm
red
laser
use
facsdiva
softwar
sampl
acquir
record
min
medium
flow
rate
singlestain
compens
control
well
neg
fluoresc
minu
one
fmo
control
includ
titrat
antibodi
perform
prior
experi
order
determin
optim
stain
concentr
count
cell
sampl
calcul
accord
manufactur
instruct
cellsl
total
number
cell
count
dilut
factor
l
fluorospher
ad
assay
concentr
fluorospher
total
number
fluorospher
count
total
volum
licens
conduct
anim
experi
obtain
danish
ministri
justic
anim
experiment
inspector
hell
r
juulmadsen
experi
conduct
accord
ethic
guidelin
data
except
viral
load
measur
qrtpcr
found
normal
distribut
analys
data
mblibv
bind
assay
valu
addit
mbl
ligand
compar
valu
specif
ligand
ad
use
analysi
varianc
principl
case
signific
effect
p
given
mbl
ligand
consid
affect
mblibv
bind
viral
load
due
pool
sampl
pool
per
group
test
sublin
differ
viral
load
far
normal
distribut
test
use
test
sublin
effect
viral
load
test
perform
data
day
test
sublin
effect
observ
distribut
three
viral
load
categori
viral
load
viral
load
viral
load
test
test
null
hypothesi
observ
distribut
equal
sublin
categori
model
use
ibvspecif
igg
antibodi
titr
measur
elisa
ijk
w
j
l
k
twl
ikj
e
ijk
overal
mean
fix
effect
treatment
w
j
fix
effect
week
j
l
k
fix
effect
line
k
variou
interact
effect
ijk
e
ijk
expect
normal
distribut
avoid
week
littl
antibodi
titr
antibodi
titr
statist
analys
week
model
use
absolut
count
tcell
subset
measur
flow
cytometri
ijk
w
j
l
k
lw
jk
tl
ik
twl
ikj
e
ijk
overal
mean
fix
effect
treatment
w
j
fix
effect
week
j
l
k
fix
effect
line
k
variou
interact
effect
ijk
e
ijk
expect
normal
distribut
model
use
absolut
count
bcell
measur
flow
cytometri
ij
l
j
tl
ij
e
ij
overal
mean
fix
effect
treatment
l
j
fix
effect
line
j
variou
interact
effect
ij
e
ij
expect
normal
distribut
analysi
varianc
perform
glm
procedur
sa
softwar
sa
institut
inc
elisa
protocol
use
measur
bind
mbl
ibv
result
fig
show
purifi
mbl
bind
ibvcoat
plate
dosedepend
manner
fig
mbl
serum
sampl
also
shown
bind
ibv
fig
c
bind
inhibit
ad
mbl
ligand
thu
addit
mannan
fo
reduc
mblibv
bind
significantli
p
serum
sampl
addit
chitosan
show
tendenc
inhibit
mblibv
bind
p
mbl
serum
bind
significantli
inhibit
mannan
fo
p
chitosan
addit
edta
serum
sampl
inhibit
mblibv
bind
significantli
p
sublin
indic
bind
calcium
depend
hand
neg
control
galactos
influenc
mblibv
bind
chicken
test
mbl
haplotyp
describ
kjaerup
et
al
determin
taqman
snp
genotyp
techniqu
data
shown
chicken
homozyg
haplotyp
chicken
homozyg
haplotyp
except
five
chicken
heterozyg
found
group
n
n
n
ibvspecif
qrtpcr
use
monitor
presenc
ibv
genom
opa
swab
sampl
day
fig
three
swab
sampl
sublin
pool
base
treatment
group
day
result
statist
analys
regardless
treatment
tabl
sinc
three
measur
per
sublin
treatment
group
day
consid
insuffici
statist
gener
chicken
higher
viral
load
chicken
viral
load
peak
day
wherea
peak
day
viral
load
tabl
significantli
larger
number
chicken
low
viral
load
contrari
significantli
larger
number
chicken
high
viral
load
p
henc
viral
load
indic
chicken
less
sever
affect
infect
chicken
ibvspecif
igg
antibodi
titr
measur
use
elisa
fig
chicken
nonrespond
remain
seroneg
chicken
two
treatment
group
n
n
four
treatment
group
n
n
n
exclud
statist
analysi
ibvspecif
igg
titr
chicken
respond
chicken
paramet
therefor
measur
chicken
maintain
statist
analysi
paramet
compar
sublin
group
group
differ
significantli
ibvspecif
igg
antibodi
titr
p
group
antibodi
titr
chicken
higher
antibodi
titr
chicken
second
vaccin
week
rest
experiment
period
antibodi
titr
show
differ
chicken
four
treatment
group
hand
antibodi
titr
show
differ
treatment
group
week
group
group
group
group
week
group
group
week
group
group
week
group
group
week
group
group
week
group
group
p
summari
ibvspecif
igg
antibodi
titr
chicken
differ
treatment
wherea
addit
mbl
ligand
vaccin
especi
fo
seem
enhanc
product
ibvspecif
igg
antibodi
chicken
chicken
absolut
count
flow
cytometr
protocol
use
nolys
nowash
method
describ
selig
et
al
use
quantifi
tcell
subset
whole
blood
tcell
subset
identifi
fscssc
gate
small
lymphocyt
follow
identif
cell
tcell
final
subdivid
cell
total
cell
ie
cell
cell
fig
b
cell
combin
total
cell
due
individu
differ
count
cell
anim
herit
origin
hala
et
al
result
present
fig
compar
count
two
sublin
within
treatment
group
fig
number
total
cell
show
differ
group
group
count
total
cell
significantli
higher
week
p
pronounc
differ
seen
group
count
total
cell
significantli
higher
week
p
count
cell
higher
group
week
p
wherea
count
cell
higher
group
week
p
cell
differ
within
group
group
week
p
briefli
addit
fo
vaccin
increas
number
total
cell
chicken
compar
chicken
chicken
show
signific
increas
number
cell
first
vaccin
mbl
ligand
ad
vaccin
compar
chicken
comparison
count
treatment
group
within
sublin
present
fig
count
total
cell
show
differ
treatment
group
neither
sublin
except
sublin
week
group
group
chicken
treatment
group
show
significantli
higher
count
total
cell
chicken
treatment
group
p
number
cell
sublin
differ
significantli
treatment
group
week
group
group
chicken
treatment
group
significantli
lower
number
chicken
treatment
group
p
besid
number
cell
differ
significantli
treatment
group
week
group
group
p
number
cell
differ
significantli
treatment
group
week
group
group
p
number
cell
differ
significantli
sublin
treatment
group
week
group
group
week
group
week
group
week
group
week
group
p
number
cell
treatment
group
lower
treatment
group
week
besid
number
cell
differ
significantli
treatment
group
week
group
week
group
week
group
p
chicken
treatment
group
lower
number
cell
treatment
group
week
briefli
addit
mbl
ligand
influenc
total
cell
within
sublin
howev
addit
chitosan
vaccin
decreas
number
cell
chicken
week
also
chicken
well
chicken
also
show
increas
number
tcell
mbl
ligand
ad
vaccin
pronouncedli
first
vaccin
bcell
identifi
fscssc
gate
small
lymphocyt
follow
identif
posit
cell
fig
c
result
shown
tabl
signific
differ
fig
ibvspecif
igg
antibodi
titr
measur
elisa
result
shown
mean
valu
sem
asterisk
indic
statist
signific
differ
p
group
sublin
doubl
asterisk
indic
statist
signific
differ
p
group
sublin
h
l
indic
sublin
high
low
mbl
serum
concentr
respect
indic
treatment
group
vaccin
vaccin
mannan
vaccin
chitosan
vaccin
fo
chicken
observ
treatment
group
absolut
count
bcell
significantli
lower
chicken
chicken
p
signific
differ
observ
chicken
treatment
group
main
purpos
present
studi
investig
innat
adapt
immun
respons
follow
ibv
vaccin
temporarili
inhibit
mbl
function
coadminist
mbl
ligand
bind
pathogen
prr
mbl
import
step
initi
earli
host
respons
infect
mbl
effici
neutralis
pathogen
via
complement
membraneattack
complex
adapt
immun
respons
need
thu
poor
adapt
memori
obtain
purpos
vaccin
unachiev
knowledg
current
studi
first
show
mbl
bind
ibv
bind
shown
occur
crd
mbl
sinc
bind
inhibit
edta
well
mannan
previou
studi
shown
human
mbl
bind
sever
virus
hiv
saifuddin
et
al
sar
ip
et
al
bind
also
shown
occur
crd
mbl
current
studi
show
mbl
bind
ibv
dosedepend
manner
besid
also
provid
evid
fo
mbl
ligand
potenti
inhibit
mblibv
bind
molecul
epstein
et
al
takahashi
et
al
serum
sampl
chicken
chitosan
show
tendenc
inhibit
mblibv
bind
p
indic
chitosan
may
also
mbl
ligand
chitosan
highli
basic
polysaccharid
obtain
deacetyl
chitin
linear
polym
nacetyldglucosamin
ravi
kumar
known
mbl
ligand
epstein
et
al
chitosan
insolubl
water
uncertainti
concern
precis
amount
chitosan
ad
bind
assay
vaccin
given
chicken
previou
studi
chitosan
deriv
n
n
ntrimethyl
chitosan
tmc
use
adjuv
vaccin
raccoon
fri
et
al
studi
show
higher
number
respond
vaccin
tmc
ad
instead
chitosan
tmc
watersolubl
immunogen
adhes
properti
chitosan
kotz
et
al
hindsight
tmc
instead
chitosan
probabl
would
better
choic
possibl
mbl
ligand
ad
ibv
vaccin
avoid
uncertainti
concentr
use
follow
first
ibv
vaccin
presenc
viral
genom
observ
opa
bird
howev
viral
load
lower
chicken
chicken
fig
indic
chicken
less
sever
affect
infect
chicken
previous
juul
madsen
et
al
find
statist
differ
viru
load
chicken
vaccin
incongru
current
studi
vaccin
part
previou
studi
could
explain
larger
anim
group
current
studi
give
accur
outcom
besid
estim
viral
load
use
qrtpcr
accur
estim
viral
load
gel
higher
viral
load
howev
support
previou
suggest
mbl
associ
suscept
ibv
infect
juulmadsen
et
al
juulmadsen
et
al
ibvspecif
igg
antibodi
titr
first
vaccin
differ
sublin
treatment
second
vaccin
week
chicken
receiv
vaccin
alon
boost
effect
vaccin
found
two
sublin
hand
ibvspecif
igg
antibodi
titr
second
vaccin
chicken
receiv
mbl
ligand
togeth
vaccin
increas
antibodi
titr
receiv
vaccin
alon
fig
pronounc
chicken
receiv
vaccin
fo
also
contrast
challeng
studi
juul
madsen
et
al
titr
lower
chicken
receiv
mannan
togeth
vaccin
compar
chicken
receiv
vaccin
alon
explan
antibodi
titr
chicken
treatment
group
combin
result
mblibv
bind
assay
mblibv
bind
clearli
inhibit
addit
ligand
serum
impli
combin
high
mbl
serum
concentr
addit
mbl
ligand
impact
develop
ibvspecif
igg
antibodi
increas
antibodi
titr
earlier
report
chicken
vaccin
eimeria
janardhana
et
al
mice
vaccin
infect
salmonella
benyacoub
et
al
feed
diet
contain
fo
dramat
increas
antibodi
titr
vaccin
fo
may
benefici
breed
sinc
transfer
matern
antibodi
offspr
import
protect
newli
hatch
chick
protect
would
increas
increas
amount
antibodi
dam
sinc
direct
relationship
ibvspecif
igg
level
dam
offspr
hamal
et
al
flow
cytometrybas
method
count
absolut
number
peripher
blood
cell
previous
describ
burgess
davison
selig
et
al
current
studi
flow
cytometri
use
identifi
phenotyp
differ
chicken
sublin
vaccin
without
addit
mblligand
gener
differ
observ
amount
total
cell
sublin
treatment
group
differ
two
sublin
within
treatment
group
observ
group
howev
addit
fo
vaccin
gave
higher
number
total
cell
chicken
chicken
fig
despit
differ
amount
bcell
week
tabl
observ
group
indic
increas
may
caus
instead
support
studi
guo
et
al
indic
activ
immedi
ibv
infect
respons
cell
mostli
cytotox
tlymphocyt
ctl
crucial
elimin
viru
local
infect
site
collisson
et
al
guo
et
al
juulmadsen
et
al
increas
number
cell
inde
observ
current
studi
may
support
suggest
collisson
et
al
ctl
import
protect
ibv
howev
increas
repress
chicken
treat
fig
b
absolut
count
total
cell
shown
left
column
absolut
count
cell
shown
middl
column
absolut
count
cell
shown
right
column
upper
panel
show
comparison
sublin
group
second
upper
panel
comparison
sublin
group
second
lower
panel
comparison
sublin
group
lower
panel
comparison
sublin
group
result
shown
mean
valu
sem
asterisk
indic
statist
signific
differ
p
group
doubl
asterisk
indic
statist
signific
differ
p
group
h
l
indic
sublin
high
low
mbl
serum
concentr
respect
indic
treatment
group
vaccin
vaccin
mannan
vaccin
chitosan
vaccin
fo
vaccin
mbl
ligand
week
fig
studi
contain
mock
vaccin
group
rule
increas
agedepend
involv
receptor
specif
use
mbl
ligand
may
influenc
differ
observ
current
studi
howev
mbl
influenc
differ
pronounc
chicken
chicken
ibvspecif
igg
antibodi
titr
number
cell
chicken
cell
circul
mostli
tcell
may
contribut
circul
tcell
healthi
adult
chicken
dalgaard
et
al
indic
may
play
import
role
chicken
immun
system
three
group
receiv
vaccin
mbl
ligand
tcell
respons
pronounc
chicken
chicken
fig
also
tendenc
p
group
receiv
vaccin
alon
increas
also
observ
studi
juul
madsen
et
al
studi
show
higher
increas
percentag
tcell
ibv
vaccin
group
receiv
vaccin
mannan
current
studi
differ
observ
tcell
respons
chicken
within
treatment
group
fig
inconsist
may
explain
use
live
viru
previou
studi
versu
use
attenu
live
viru
current
studi
alreadi
suggest
howev
least
tendenc
higher
number
tcell
observ
current
studi
week
chicken
receiv
vaccin
mbl
ligand
compar
chicken
receiv
vaccin
alon
fig
observ
chicken
receiv
vaccin
chitosan
fo
week
week
asterisk
indic
statist
signific
differ
p
group
doubl
asterisk
indic
statist
signific
differ
p
group
h
l
indic
sublin
high
low
mbl
serum
concentr
respect
indic
treatment
group
vaccin
vaccin
mannan
vaccin
chitosan
vaccin
fo
treatment
group
receiv
vaccin
mbl
ligand
fig
function
chicken
tcell
still
debat
studi
indic
tcell
respond
pathogen
provid
protect
immun
respons
immunis
live
attenu
nonattenu
salmonella
strain
berndt
et
al
result
current
studi
may
support
indic
sinc
result
show
tcell
increas
ibv
vaccin
mbl
inhibit
differ
amount
bcell
week
tabl
observ
chicken
receiv
vaccin
differ
observ
ibvspecif
antibodi
titr
group
treatment
group
receiv
vaccin
fo
major
differ
chicken
observ
ibvspecif
antibodi
titr
even
though
tendenc
p
differ
amount
bcell
week
observ
chicken
find
support
suggest
made
guttormsen
et
al
increas
igg
respons
mbldefici
mice
attribut
increas
number
bcell
increas
igg
may
also
caus
ig
class
switch
previous
observ
mice
dietari
fo
nakamura
et
al
previou
challeng
studi
shown
regul
igg
speci
low
amount
mbl
mice
guttormsen
et
al
chicken
juulmadsen
et
al
likewis
ruseva
et
al
argu
genet
environ
influenc
modifi
effect
mbl
conclud
whether
differ
amount
bcell
week
observ
chicken
receiv
vaccin
alon
current
studi
caus
vaccin
age
differ
caus
vaccin
mbl
ligand
elimin
differ
conclus
ibvspecif
igg
antibodi
titr
chicken
differ
treatment
wherea
addit
mbl
ligand
vaccin
especi
fo
seem
enhanc
product
ibvspecif
igg
antibodi
chicken
chicken
addit
fo
vaccin
also
increas
number
total
cell
chicken
combin
unchang
amount
bcell
week
compar
chicken
chicken
well
chicken
also
show
increas
number
tcell
mbl
ligand
ad
vaccin
pronouncedli
first
vaccin
suggest
tcell
may
also
play
role
immun
respons
ibv
result
indic
previous
suggest
juul
madsen
et
al
mbl
involv
adapt
immun
respons
ibv
vaccin
mbl
inhibit
may
therefor
benefici
achiev
high
antibodi
respons
vaccin
studi
need
elucid
whether
addit
mbl
ligand
ibv
vaccin
give
better
immun
protect
ibv
infect
research
infrastructur
action
grant
agreement
nadir
